Molecular Data Inc
NASDAQ:MKD
Gross Margin
Molecular Data Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 26.8k USD |
Gross Margin |
0%
|
Country | US |
Market Cap | 1.9T USD |
Gross Margin |
47%
|
Country | ZA |
Market Cap | 738.6B Zac |
Gross Margin |
35%
|
Country | UK |
Market Cap | 201.8B GBP |
Gross Margin |
44%
|
Country | CN |
Market Cap | 189.8B USD |
Gross Margin |
38%
|
Country | CN |
Market Cap | 165.3B USD |
Gross Margin |
63%
|
Country | CN |
Market Cap | 683.8B HKD |
Gross Margin |
35%
|
Country | NL |
Market Cap | 80.3B EUR |
Gross Margin |
37%
|
Country | UY |
Market Cap | 1.3T MXN |
Gross Margin |
50%
|
Country | AR |
Market Cap | 72.5B USD |
Gross Margin |
50%
|
Country | US |
Market Cap | 51.4B USD |
Gross Margin |
47%
|
Profitability Report
View the profitability report to see the full profitability analysis for Molecular Data Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Molecular Data Inc's most recent financial statements, the company has Gross Margin of -0.1%.